Taken together, these results indicate that, in breast cancer, paracrine/autocrine IGFs are positive modulators of DDR1 expression, and help explaining the frequent DDR1 overexpression in a variety of malignancies with dysregulated IGF axis. Here, IGF1 is linked to breast cancer.